Donald M. Berwick, MD, MPP; Saranya Loehrer, MD, MPH; Christina Gunther-Murphy, MBA
JAMA. 2017;317(21):2161-2162. doi:10.1001/jama.2017.4703
This Viewpoint summarizes rules in health care organizations that their own leaders identified as ones that contribute little or no value to care, impede the work of clinicians, frustrate patients and families, and waste time and resources.
Aaron Hakim, MS; Joseph S. Ross, MD, MHS
JAMA. 2017;317(21):2163-2164. doi:10.1001/jama.2017.5202
This Viewpoint explores why biosimilars for chronic diseases, the largest category of biological therapies, are unlikely to yield cost savings.